Upcoming program speakers

Speakers who have been there, done that from both the sponsor and service side attend Outsourced Pharma to openly dialogue with you. In our sessions, authentic discussion between panelists is equaled by the energetic participation of attendees. True story: a panelist described the audience involvement as so boisterous, "it was like they were on the panel!"

Check out the top-shelf line-up.

Speakers Application

side background


Speakers by Show

Boston 2018

Confirmed speakers include:
Agios Pharmaceuticals | Suzanne Murray, VP, Quality
Alcresta Pharmaceuticals | David Brown, VP, Tech Ops
Allena Pharmaceuticals | Hugh Wight, VP, Technical Operations
Avara Pharmaceutical SolutionsBill Pasek, EVP & Chief Commercial Officer
Biogen | Thomas Holmes, Sr. Dir., Global External Manufacturing
Biogen | Lee Spach, Director, Global Product & Supply Chain Security
BioProcess Technology Consultants | Patricia Seymour, Sr. Consultant
Catabasis Pharmaceuticals | Sachin Chandran, Director, Pharmaceutical Sciences
Compass Therapeutics | Greg Zarbis-Papastoitsis, VP, Process & Manufacturing Sciences
Concordia ValSource | Mike Long, Sr. Dir., Consulting Services & Principal Consultant
Decibel Therapeutics | John Lee, SVP, Pharmaceutical Development
Eli Lilly and Company | Mark Butchko, Sr. Dir., QA, Product Research & Dev.
FDA | Paula Katz, Director, Manufacturing Quality Guidance & Policy Staff
Freedom Bioscience Partners | Brian Scanlan, Managing Partner
GMP Operations Consulting, LLC | Brian Clark, Principal
Kala Pharmaceuticals | Vincent Kosewski, SVP, Manufacturing & Supply Chain Management
Keryx Biopharmaceuticals | Christine Carberry, COO
Kyn Therapeutics | Jim Nolan, Head, CMC
Lifecard Services | Ron Guido, President
Mersana Therapeutics | Michael Kaufman, SVP, CMC
Mersana Therapeutics | Timothy Lowinger, Chief Scientific Officer
Mersana Therapeutics | Anna Protopapas, President & CEO
Mersana Therapeutics| Tom Wagler, Executive Director, Drug Substance Development
Mersana Therapeutics | Lisa Wyman, Executive Director, Quality
Neuralstem | Thomas Hazel, SVP, Research
Outsourced Pharma | Louis Garguilo, Conference Chair & Chief Editor
PharmoRx Therapeutics | Carl J. Accettura, VP & General Manager
Piramal Pharma Solutions | Vince Ammoscato, VP, Site Head
Promedior | Scott Willett, VP, Biopharmaceutical Development
Radius Health | Michael Markey, CMC Director, Pharmaceutical Sciences
Rondaxe Pharma | Brian James, SVP, Operations
Sanofi | Chirag V. Shah, Director, Global Product Security
Shire | Barbara Glantschnig, VP, Quality
Skyland Analytics | Robert Di Scipio, CEO
Tunnell Consulting | Julia O'Neill, Principal


Philadelphia 2018

Confirmed speakers include:
AstraZeneca | Vimal Gandhi, Director, Global Biosimilar Operations & Strategy
Outsourced Pharma | Louis Garguilo, Conference Chair, Chief Editor
Avara Pharmaceutical Solutions | Warren Horton, EVP, Global Quality Assurance
QR Pharma | Maria Maccecchini, CEO
Drive DeVilbiss Healthcare | Dawn Rubel, SVP, Quality & Regulatory Affairs
Synergy Pharmaceuticals | Chhaya Shah, SVP, Manufacturing & Technical Operations
Core Riks | Jack Solomon, Practice Leader, Supply Chain
Tunnell Consulting | Kip Wolf, Senior Managing Consultant

Past Programs

We're proud of the speakers who've given their time and talent to our programs. Below are just a few of our past participants - bravo!
Achaogen | Tina Larson, VP Technical Operations
ADC Therapeutics | Michael Mulkerrin, VP, Head of CMC
Agensys | Brian Mendelsohn, Leader of ADC Chemistry Group
Allergan | Sesha Neervannan, SVP Pharmaceutical Development
Alnylam Pharmaceuticals | John Frenz, VP Manufacturing
Amunix Operating Inc. | Ulrich Ernst, SVP Manufacturing & Quality Operations
Arcturus Therapeutics | Joseph Payne, President and CEO
BalinBac Therapeutics | John Gregg, President and CEO
Biogen | Thomas Holmes, Sir. Dir. Global External Manufacturing
Capricor Therapeutics | Denise McDade, VP of Quality
Cerulean Pharma | Marc Wolfgang, VP Technical Operations
CytRx | Carrie Helland, VP Project Management and Manufacturing
Depomed | Gerd Kochendoerfer, VP Pharmaceutical Development
Eleven Biotherapeutics | Greg Zarbis-Papastoitsis, VP Process and Manufacturing Sciences
Endocyte | Michael Brinkley, VP Quality
EPRIUS Biopharmaceuticals | Charles Laranjeira, VP Supply Operations
FORMA Therapeutics | Mary Kachinsky, VP Strategic Sourcing & Operations
Genentech | Todd Mabe, Head of External Quality, Biologic Drug Substance
Genzyme | Piet Houwen, Head of External Manufacturing
Innovent Biologics | Claudia Lin, VP Quality
J&J | Courtney Billington, VP Global Pharmaceutical Supply Chain
Medivation | Thomas Templeman, SVP Pharmaceutical Operations
Merck | Bob Kanuga, VP External Manufacturing
Mirati Therapeutics | Dennis Hester, VP Product Development and Head of CMC
Moderna Therapeutics | Hari Pujar, VP Tech Development & Manufacturing
Nektar | Maninder Hora, SVP Pharmaceutical Development and Manufacturing Operations
Neurocrine Biosciences | Scott Zook, Vice President, CMC Development
Orexigen | Philip Roberts, VP Technical Operations
Pernix Therapeutics | Terry Novak, COO
Polynoma | Pat Mallon, COO
Retrophin | Nils Olsson, VP CMC
Revance Therapeutics | Azita Nejad, VP Quality
Shire | Charlene Banard, SVP Quality
Shire | Mani Sundararajan, VP & Head Global Pharmaceutical Technology
Stemline Therapeutics | Joan Connolly, VP Manufacturing
Sorrento Therapeutics | Jeffrey Su, EVP & COO
Sunovion | Vincent Kosewski, VP Supply Chain Operations
Theravance Biopharma | Junning Lee, SVP Technical Operations
Versartis | Patrick Murphy, VP Manufacturing
XenoPort | Sami Karaborni, VP Development Operations